What: Shares of Cepheid , a developer of molecular diagnostic tests used in managing infectious diseases and cancer, plunged around 12% today after the company reported its second-quarter earnings ...

We have seen $171,209,458 of award payments to $DHR over the last year. $DHR insiders have traded $DHR stock on the open market 8 times in the past 6 months. Of those ...

We recently published a list of 10 Best Healthcare Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against the other ...